Plain-English translation of NCT07251179 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to better understand autoimmune diseases—conditions where your immune system mistakenly attacks your own body—by studying specific immune cells in your blood. This study will collect blood samples from up to 200 people diagnosed with lupus, scleroderma, vasculitis, antiphospholipid syndrome, or primary immune deficiencies. By examining these samples closely, scientists hope to identify which immune cells are causing disease and why some current treatments work better than others.
Current treatments that reduce B cells (a type of immune cell) sometimes help autoimmune patients, but not always, and doctors don't fully understand why. This research aims to identify the specific 'bad' immune cells responsible for disease so that future treatments can target them more precisely, potentially offering better results with fewer side effects.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will visit the research center in Strasbourg and have blood drawn—similar to a routine blood test. Researchers will use advanced technology to study your immune cells in detail. The study does not involve any medication or invasive procedures. Your participation helps scientists build a database of immune cell patterns across different autoimmune diseases to guide future treatments.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
France